Samaneh Rashidi
About
My research project
Investigating the Effects of Brain stimulation on Language Abilities
My project aims to develop a non-invasive and relatively safe neuromodulating technique for improving language learning. In this project, I will examine how brain stimulation could enhance our language abilities. I will use a novel artificial intelligence approach to personalise these brain-based interventions, that have been shown to improve other cognitive functions, in order to maximise their benefit on language abilities in healthy individuals. I believe my project will pave the way using psychological and neuroscientific knowledge, together with methods from AI, to improve language performance.
This project has great promise for millions of individuals who try to learn new languages and many who struggle with the acquisition of such new skill due to atypical development, healthy aging, or an acquired brain-based disease. My project has the potential to develop a non-invasive neuromodulating technique for improving the performance of translator. This approach has a high chance of filing patent to be developed as a commercial device for non-invasive cognitive enhancement in language learning.
Supervisors
My qualifications
Research
Research interests
I love research. I am interested in human study, neurological disorders and mental health. Since the start of my MSc I have been working on the topics of system and quantitative neuroscience and working on multidisciplinary approaches for treatment of neurodegenerative and cognitive disorders.
I participated in conducting several clinical trials in using different brain-based interventions techniques including transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), Neurofeedback training (NFT), transcutaneous electrical nerve stimulation (TENS) and pulsed electromagnetic fields (PEMFs) in combination with EEG and behavioural assessment tools in diseases like attention deficit hyperactivity disorder (ADHD), tinnitus, musculoskeletal disorders (MSDs), depression, and patients with chronic pains.